Assignee
NABRIVA THERAPEUTICS AG
AT·7 granted patents·2 pending applications·250 citations·filing 2003–2017
Top patents by PatentIndex Score
9 records- 0196US7534814B2Mutilin derivatives and their use as antibacterialsNABRIVA THERAPEUTICS AG·Filed 2004·Granted May 19, 2009·242 cites·6 claims
- 0279US7569587B2Antibacterial mutilinsNABRIVA THERAPEUTICS AG·Filed 2007·Granted Aug 4, 2009·3 cites·4 claims
- 0364US7790749B2Use of pleuromutilins for the treatment of disorders caused by Helicobacter pyloriNABRIVA THERAPEUTICS AG·Filed 2003·Granted Sep 7, 2010·2 cites·3 claims
- 0463US2014256731A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2014·Application pending·0 cites
- 0561US2017266194A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 0657US7612103B2Pleuromutilin derivatives as antimicrobialsNABRIVA THERAPEUTICS AG·Filed 2003·Granted Nov 3, 2009·3 cites·8 claims
- 0756US8624033B2Pleuromutilins and process for the preparation of pleuromutilinsNABRIVA THERAPEUTICS AG·Filed 2012·Granted Jan 7, 2014·0 cites·21 claims
- 0844US8343972B2Organic compoundsNABRIVA THERAPEUTICS AG·Filed 2006·Granted Jan 1, 2013·0 cites·18 claims
- 0926US9701628B212-epi pleuromutilinsNABRIVA THERAPEUTICS AG·Filed 2015·Granted Jul 11, 2017·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when NABRIVA THERAPEUTICS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →